ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that develops when the motor neurons carrying movement signals from your brain to your muscles slowly break down and die. It attacks both upper motor neurons in the brain and lower motor neurons in the spinal cord at the same time, which is unusually aggressive because most neurological diseases target only one layer. As those nerve cells fail, your voluntary muscles weaken, twitch, and waste away. The result is the progressive paralysis most people recognize as Lou Gehrig’s disease, with an average survival window of three to five years after diagnosis.
You will see how ALS damages your nervous system, what drives the inherited forms, why most cases appear without any family warning, and what scientists still cannot fully explain.
What Actually Happens Inside the Body During ALS
Motor neurons are long, delicate wiring cells. Upper ones sit in your brain’s motor cortex and send the original “move” command. Lower ones live in your brainstem and spinal cord and relay that command out to your muscle fibers. Healthy movement depends on both layers staying intact and connected. In ALS, both layers deteriorate simultaneously, so the signal path collapses from both ends at once.
When motor neurons die, the muscles they once controlled stop receiving input. Without stimulation, your muscle fibers shrink through a process called atrophy. Early symptoms often show up in your hands, feet, or throat, but the spread pattern varies from patient to patient. You might first notice slurred speech or trouble swallowing, or find that you cannot grip a doorknob or button a shirt.
Motor neurons carry a heavy metabolic load, and that load makes them vulnerable once damage starts. Survival typically falls between three and five years after symptoms appear, though roughly 10 percent of people with ALS live ten years or longer. Cases running 20 years or more do happen and tend to attract public attention because they sit far outside the average.
Why Upper and Lower Neuron Loss Matters
Most movement disorders pick one layer. Parkinson’s disease targets specific dopamine-producing cells in the midbrain. Spinal muscular atrophy hits lower motor neurons only. ALS stands out because it dismantles both layers, which produces the mixed signs doctors look for: muscle wasting from lower neuron loss alongside stiffness and brisk reflexes from upper neuron loss. That combination is part of why diagnosis can take a year or more, since the early pattern often mimics other conditions.
The Genetic Blueprint Behind Familial ALS
Around 5 to 10 percent of ALS cases run in families. Doctors call these familial cases, and they tend to follow patterns that genetic testing can identify. The other 90 to 95 percent show up without any obvious inherited trigger, and that category is called sporadic ALS.
The Genes Most Often Involved
Researchers have identified more than two dozen genes linked to familial ALS, but a small group accounts for most inherited cases:
- C9orf72: The single largest known contributor, especially in people of European ancestry. A short repeat expansion inside this gene disrupts RNA processing and may also trap proteins that motor neurons need.
- SOD1: One of the earliest ALS genes discovered. Mutations weaken the enzyme that normally clears toxic free radicals, leaving motor neurons exposed to oxidative damage.
- TARDBP: Encodes the TDP-43 protein. Mutations make the protein clump abnormally, which connects this gene directly to the protein-aggregation problem seen in nearly every ALS case.
- FUS: Similar to TARDBP in function. FUS mutations disturb how RNA is handled inside the nucleus and drive unusually aggressive juvenile-onset cases in some families.
Even within the same family carrying the same mutation, age of onset can shift by decades. A parent might develop ALS at 60 while their child shows symptoms at 35, or a sibling might never develop the disease at all. That variability tells scientists that genes alone do not seal the outcome. Other biological and environmental factors still have to line up.
| Gene | Main Role in Motor Neurons | Notes on Inheritance |
|---|---|---|
| C9orf72 | RNA processing and protein trafficking | Most common familial cause, especially European ancestry |
| SOD1 | Detoxifies free radicals | First ALS gene discovered, broad global spread |
| TARDBP | RNA binding and splicing | Same protein implicated in sporadic ALS |
| FUS | DNA repair and RNA transport | Often linked to younger onset |
Why Sporadic ALS Has No Obvious Family History
The remaining 90 to 95 percent of ALS cases happen in people with no family pattern. Doctors call these sporadic, though the label can mislead. Sporadic does not mean random in the scientific sense; it means the trigger is not a single inherited mutation that testing can catch. Polygenic risk, where many small gene variations each nudge vulnerability upward, plays a real role. So can de novo mutations, which are brand-new genetic changes that appear in a person without being present in either parent.
The TDP-43 Connection Across ALS Types
One striking finding has held up across hundreds of studies. Abnormal clumping of the TDP-43 protein shows up in roughly 97 percent of all ALS cases, familial or sporadic. This shared pathology suggests that no matter what kicks the disease off, the motor neurons tend to converge on the same biological endpoint. Think of it as different roads leading to the same bridge collapse. Knowing which road the patient traveled matters less than understanding why the bridge fails.
That is why scientists study TDP-43 so intensely. It represents a common final mechanism rather than a starting cause, and it offers a target that could help both inherited and non-inherited forms.
The Leading Biological Mechanisms Behind Motor Neuron Death
Researchers no longer look for one single cause. Instead, they focus on several overlapping biological mechanisms that together push motor neurons past the point of no return. The leading candidates explain different parts of the picture and often reinforce each other.
Glutamate Excitotoxicity
Glutamate is a chemical messenger that motor neurons use to talk to each other. In ALS, something goes wrong with the cleanup step. Excess glutamate hangs around the synapse, overstimulating the receiving neuron until it burns out. This hypothesis has driven much of the drug-development work in the field because blocking glutamate signaling can slow damage in some patients.
Oxidative Stress
Motor neurons burn a lot of energy and have a high metabolic rate. That makes them unusually sensitive to oxidative stress, the cellular wear and tear caused by reactive oxygen molecules called free radicals. When antioxidant defenses fall behind, the internal machinery of motor neurons starts to corrode. The SOD1 gene fits here directly, since it normally helps neutralize those free radicals.
Misfolded Proteins and Aggregation
TDP-43, SOD1, and FUS can all misfold and clump together inside or between cells. These aggregates block normal transport along motor neuron axons and disrupt communication with neighboring cells. Protein aggregation may not be the first domino to fall, but it acts as a serious accelerant once it starts.
Why the Mechanisms Overlap
Most ALS cases likely involve several of these processes at once. Oxidative stress makes neurons more vulnerable to glutamate excitotoxicity. Protein aggregation disrupts the cleanup of glutamate. Aging slows the repair systems that would normally hold everything together. That layering is one of the main reasons finding a single cure has been so difficult.
Environmental and Lifestyle Factors That Raise ALS Risk
No lifestyle choice has been proven to cause ALS outright, but several exposures show up more often in ALS patients than in the general population. The associations are real enough to take seriously without being strong enough to blame any single exposure.
Military Service
Military veterans develop ALS at noticeably higher rates than civilians. The exact cause is still debated, with proposed explanations including traumatic brain injury, intense physical exertion, and chemical exposures during service. Large epidemiological studies reviewed by organizations such as the ALS Association have produced data strong enough to act on, and the U.S. Department of Veterans Affairs recognizes ALS as a service-connected condition for many veterans.
Smoking and Chemical Exposure
Smoking is one of the few modifiable risk factors with consistent support. Heavy smokers face a modestly higher ALS risk than non-smokers. Exposure to heavy metals, pesticides, and certain industrial chemicals has also been linked to higher ALS likelihood in regional studies, though results vary by population.
Head Trauma and Athletic History
Repeated head trauma, including concussions from contact sports, has been associated with higher ALS risk in some studies. Professional football players and soccer players have appeared in research at rates higher than expected. The link is still debated because head trauma studies are hard to design cleanly, but the signal keeps showing up.
Demographic Risk Factors That Stay Constant
Some risk factors cannot be changed. Age between 55 and 75 marks the most common window for symptom onset. Men develop ALS slightly more often than women, especially before age 65, though the gap narrows later in life. A family history of ALS or frontotemporal dementia raises risk modestly, even when no single mutation can be found.
These exposures do not cause ALS on their own. They appear to combine with underlying genetic susceptibility and age-related wear to push vulnerable motor neurons past a tipping point that healthy neurons would tolerate.
Why Scientists Have Not Found One Single Cause of ALS
After decades of research, ALS still has no single identified cause. That frustrates patients and families, and the frustration is reasonable. But the absence of one trigger reflects how complex neurodegenerative conditions actually work, rather than a failure of the science.
ALS Is Multifactorial by Nature
Most ALS cases involve a stack of contributing factors: subtle inherited risk from many small genes, biological aging, environmental exposures, and the slow accumulation of cellular damage. Different patients arrive at the disease through different combinations. Someone with a strong C9orf72 mutation might need only mild environmental exposure to cross the threshold. Someone with no family history might need a heavier combination of age, toxins, and biological stress to reach the same point.
What the Approved Treatments Reveal About the Causes
The few treatments that exist today offer a clue. Riluzole reduces glutamate excitotoxicity. Edaravone works as an antioxidant and targets oxidative stress. Both modestly slow progression, and both target mechanisms that show up repeatedly in the cause research. Even the available treatments are aimed at the same overlapping pathways scientists study as causes, which suggests the field has identified the right biological terrain even if it has not mapped every road into it.
What This Means for Patients and Families
Understanding the layered causes helps families interpret genetic testing results and set realistic expectations about prevention and prognosis. A negative genetic test does not rule out inherited risk from polygenic sources. A positive environmental exposure does not mean ALS was inevitable. The disease sits at the intersection of vulnerability and trigger, and the mix differs for each person.
- Family risk: Roughly 1 in 50 cases involves a clearly inherited mutation, though polygenic risk can run higher.
- Personal history: Smoking, head trauma, and military service can shift risk upward but do not cause ALS alone.
- Age: The risk window between 55 and 75 reflects how aging interacts with all the other factors.
- Genetic testing: Useful for some families, but a negative result does not eliminate inherited contribution.
The Big Picture
ALS does not come from one broken switch. It comes from a stack of overlapping forces, including genetic vulnerability, protein mishandling, glutamate overload, oxidative damage, and years of environmental stress, that push your motor neurons past the point of recovery. Knowing the layers helps explain why the disease varies so widely from person to person and why prevention strategies have remained elusive.
FAQ
What actually causes ALS?
ALS develops when the motor neurons in your brain and spinal cord progressively degenerate, cutting off the signals that control voluntary movement. The trigger varies by patient and usually involves a combination of genetic risk, aging, biological stress, and environmental exposures rather than one single cause.
Is ALS hereditary?
About 5 to 10 percent of cases are inherited through identifiable mutations in genes such as C9orf72, SOD1, TARDBP, and FUS. The remaining 90 to 95 percent show up without an obvious family pattern, though subtle genetic risk and de novo mutations still play a role in many sporadic patients.
Can environmental factors cause ALS?
Military service members face a notably higher ALS diagnosis rate than civilians, according to decades of veteran health research. Smoking, head trauma, and exposure to heavy metals or pesticides have been linked to higher ALS risk in some studies, and military veterans develop ALS at noticeably higher rates than civilians, but these factors only raise the odds rather than acting as a direct cause.
Why does ALS keep getting worse over time?
Once motor neurons begin dying, the surviving cells must carry a heavier load and become more vulnerable to glutamate excitotoxicity, oxidative stress, and protein aggregation. That cascade spreads through the motor system gradually, which is why symptoms progress and function declines rather than stabilizing on their own.
What gene mutations cause ALS?
The most common ALS-related mutations affect the C9orf72, SOD1, TARDBP, and FUS genes. C9orf72 accounts for the largest share of inherited cases, especially in people of European ancestry, while SOD1 mutations were the first discovered and remain important in several family lineages worldwide.
What are the early warning signs of ALS?
Early symptoms often include muscle twitches, weakness in your hands or feet, slurred speech, difficulty swallowing, or unexplained muscle cramps. Because these signs overlap with many other conditions, diagnosis usually involves a neurologist ruling out alternative causes through examination, imaging, and specialized testing.
